Patient P-01747

Synthetic patientNBL-101 · Day 117 · 55–64 · F · baseline S15Steering view · 3D Open companion preview

Therapy response

Favorable

Tolerance

Improving

GI state

Deteriorating

Inflammatory state

Favorable

Nutritional resilience

Declining

Discontinuation risk

45%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 NBL-101 started — Baseline state S15
Day 13 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 13.

Primary contributors, last 14 days

GI instability+20
Nutritional resilience-10
Toxicity-10
Inflammatory activity+2

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden

Companion

32.4/100

worsening · +7.0 vs previous 14 d

Toxicity

Blood

16.3/100

improving · -7.9 vs previous 14 d

Sleep quality

Wearable

59.7/100

improving · +2.6 vs previous 14 d

Energy level

Daily log

5.7/10

improving · +0.2 vs previous 14 d

Stress level

Daily log

4.7/10

stable · +0.1 vs previous 14 d

Steps

Wearable

7,442

stable · -140 vs previous 14 d

Adherence

Companion

91 %

stable · +0.7 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 67 from the failing basin, 21 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.

Would not help

Nothing clearly counter-productive in the record.

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Histamine load
-1.4no signal · 24%
Spicy / capsaicin
+1.3no signal · 21%
Alcohol
+0.9no signal · 16%
Simple carbohydrates
-0.3no signal · 15%
Insoluble fibre
+0.3no signal · 15%
Dietary fat load
-0.2no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Inflammatory signalling ↑20
- MicrobiomeBacteroides fragilis expansion

DNA

Fictional pharmacogenomic panel

CYP2D6 Normal metabolizer
Expected exposure

Microbiome

Shannon diversity 3.2 · butyrate capacity 72/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisHigh
Bifidobacterium longumLow
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 53 ms
Sleep: 7.7 h
Steps: 7,891
Resting HR: 70 bpm

Daily log: GI score 32, nutritional resilience 58, adherence 91.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-01571	47%	S13	SC-12	improved	57
P-01804	42%	S19	AD-05	improved	61
P-01724	41%	S10	DT-01	improved	63
P-01430	40%	S05	CR-01	improved	54
P-01555	38%	S06	GI-04	improved	56
P-01752	38%	S20	DT-01	improved	50
P-01593	37%	S10	HY-01	improved	56
P-01861	37%	S12	HY-01	improved	47
P-01342	36%	S11	DT-01	improved	48
P-01455	36%	S01	GI-04	improved	61
P-01346	34%	S12	DT-01	improved	52
P-01374	34%	S08	HY-01	improved	49